Recommendations from SCAI experts support the safety of PCI without on-site surgery

Published Date: 02 Mar 2023

Recommendations from SCAI experts support the safety of PCI without on-site surgery

Read Full News

Latest News

Planning Lung Cancer Screening, Surgery Between Clinicians and Patients Kevin Kunzmann

David Tom Cooke, MD, reviewed the importance of shared decision making as it relates to risk and benefit of cancer screening, as well as in more refined invasive care options.

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

Episode 3: Cracking the Code: Insulin Resistance in HS

What if your HS patient's normal labs are hiding a metabolic storm? Drs Okoye and Bordone explore overlooked clues, HOMA-IR, and real-world GLP-1 outcomes.

Medicaid Status May Worsen Complications After Heart Transplantation

Medicaid Status May Worsen Complications After Heart Transplantation

GLORIOUS: Exenatide Lacks Preventive Effect on Organ Injury in Cardiac Surgery

GLORIOUS: Exenatide Lacks Preventive Effect on Organ Injury in Cardiac Surgery

Aesthetician Charged With Injecting Customers With Counterfeit Botox

Some clients faced life-threatening injuries after receiving injections, said federal authorities

Todays Updates

Episode 159: Key Practice Takeaways From the New AAN Functional Seizure Guidelines Marco Meglio, Benjamin Tolchin, MD, MS, FAAN

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Benjamin Tolchin, MD, MS, FAAN. [LISTEN TIME: 23 minutes]

FDA Grants Orexin Agonist Alixorexton Breakthrough Therapy Designation for Narcolepsy Type 1 Isabella Ciccone, MPH

Alixorexton, an oral investigational selective orexin 2 receptor agonist, is currently in development for the treatment of narcolepsy type 1 and type 2, and idiopathic hypersomnia.

Todays Updates

Episode 159: Key Practice Takeaways From the New AAN Functional Seizure Guidelines Marco Meglio, Benjamin Tolchin, MD, MS, FAAN

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Benjamin Tolchin, MD, MS, FAAN. [LISTEN TIME: 23 minutes]

FDA Grants Orexin Agonist Alixorexton Breakthrough Therapy Designation for Narcolepsy Type 1 Isabella Ciccone, MPH

Alixorexton, an oral investigational selective orexin 2 receptor agonist, is currently in development for the treatment of narcolepsy type 1 and type 2, and idiopathic hypersomnia.

Latest News

David Tom Cooke, MD, reviewed the importance of shared decision making as it relates to risk and benefit of cancer screening, as well as in more refined invasive care options.

Anemia Correction Before Colorectal Surgery Yields No Postoperative Gains

What if your HS patient's normal labs are hiding a metabolic storm? Drs Okoye and Bordone explore overlooked clues, HOMA-IR, and real-world GLP-1 outcomes.

Medicaid Status May Worsen Complications After Heart Transplantation

GLORIOUS: Exenatide Lacks Preventive Effect on Organ Injury in Cardiac Surgery

Some clients faced life-threatening injuries after receiving injections, said federal authorities

News All Time

Telehealth Pathway for IBD Surgery Expanded Access to Care in Small Study

Conducting pre-op and post-op visits via telemedicine saved patients thousands of driving miles

New Guideline Revises Cautions Around Dental Work in Joint Replacement Patients

Surgeons' groups acknowledge that prophylactic antibiotics may not cut infection risk

How 'General Hospital' Missed a Chance to Promote Living Organ Donation

A recent storyline offered a negative spin

Half-Truths, Big Risks: The Dangers of an Incomplete Medical History

Creating an environment that fosters open communication is essential

Anthem Blue Cross Blue Shield Reverses Decision to Put a Time Limit on Anesthesia

Change comes after widespread outcry

Inside the OR: Cervical Artificial Disc Replacement

Watch orthopedic spinal surgeon Antonio Webb, MD, perform this complex procedure

Trump's FDA Pick Is MedPage Today's Former Top Editor

Marty Makary has made a name for himself challenging the medical establishment

How Impactful is EMPACT-MI on Heart Failure: EMPACT-MI Trial

The trial evaluated the efficacy of empagliflozin to reduce cardiovascular risk in patients after acute myocardial infarction.

Nationwide IV Fluid Shortage Could Change How Hospitals Manage Patient Hydration

Crisis expected to last a long time, according to one expert

One-day Decompression at Allegheny Health Network

One-day Decompression at Allegheny Health Network

Alarming Surge in Alcohol-Related Liver Transplants in Younger Adults

Targeted preventive strategies needed, especially for younger women, researchers say

Health Worker Gets 2 Years for Accessing Ruth Bader Ginsburg's Medical Records

Transplant coordinator was convicted earlier this year

The Robot Will See You Now

Robotics may not be the answer for primary care right now, but "smart systems" sure could help

Resistance Training Falls Short in Severe Hip Arthritis

Trial finds conservative approach inferior to joint replacement

People Opting Out of Organ Donation After Donor Mistakenly Declared Dead

The alleged incident even affected donations in France

I'm a Black Trauma Surgeon. Ending Gun Violence Demands Fighting for Racial Justice.

An excerpt from Williams' book, The Bodies Keep Coming

Recommended News For You

Potential targets for treating the most common type of liver cancer in children have been identified by a collaborative study.

Delay of more than 42 days for breast cancer surgery raises death risk for certain subtypes, study finds

According to new studies, some cancer patients can safely forego radiation therapy.

Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.

Dendritic Cell Therapy Offers No Survival Advantage in Pleural Mesothelioma

24 months after radical prostateectomy, no PSA recurrence was observed when using apalutamide plus ADT.

Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer

Recommended Articles For You

The Basics of M.C.V Normal Range for Better Health Management 

Understanding Hemosiderosis: Causes, Symptoms, and Treatment Options 

Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology 

Blastic Plasmacytoid Dendritic Cell Neoplasm and the Dawn of AI-powered Diagnostics 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Common intracellular toxin could help fight leukemia

2.

One-third of childhood cancer survivors experience significant fear that it could come back, study reveals

3.

Children living near oil and gas wells face higher risk of rare leukemia, studies show

4.

Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.

5.

RML to develop bone marrow transplantation at Lady Hardinge Medical College in Safdarjung

1.

The Oncologist’s Edge: Tools, Trials, and Tech Transforming Treatment

2.

Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?

3.

Innovative Bioengineering Approaches for Erectile Function Recovery After Radical Prostatectomy

4.

Ultrasound: A Promising Tool in the Fight Against Malignant Breast Cancer

5.

Transfusing the Future: Exploring the Possibilities of Blood Transfusions

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients

2.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

4.

Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC

5.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot